Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
http://dx.doi.org/10.25673/101285
Titel: | NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery : a prospective observational study |
Autor(en): | Elitok, Saban Devarajan, Prasad Bellomo, Rinaldo Isermann, Berend Haase, Michael Haase-Fielitz, Anja |
Erscheinungsdatum: | 2022 |
Art: | Artikel |
Sprache: | Englisch |
URN: | urn:nbn:de:gbv:ma9:1-1981185920-1032406 |
Schlagwörter: | Cardiopulmonary bypass Cardiorenal syndrome NGAL/hepcidin-25 ratio Subclinical AKI |
Zusammenfassung: | Background Acute kidney injury (AKI) subtypes combining kidney functional parameters and injury biomarkers may have prognostic value. We aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL)/hepcidin-25 ratio (urinary concentrations of NGAL divided by that of hepcidin-25) defined subtypes are of prognostic relevance in cardiac surgery patients. Methods We studied 198 higher-risk cardiac surgery patients. We allocated patients to four groups: Kidney Disease Improving Global Outcomes (KDIGO)-AKI-negative and NGAL/hepcidin-25 ratio-negative (no AKI), KDIGO AKI-negative and NGAL/hepcidin-25 ratio-positive (subclinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-negative (clinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-positive (combined AKI). Outcomes included in-hospital mortality (primary) and long-term mortality (secondary). Results We identified 127 (61.6%) patients with no AKI, 13 (6.6%) with subclinical, 40 (20.2%) with clinical and 18 (9.1%) with combined AKI. Subclinical AKI patients had a 23-fold greater in-hospital mortality than no AKI patients. For combined AKI vs. no AKI or clinical AKI, findings were stronger (odds ratios (ORs): 126 and 39, respectively). After adjusting for EuroScore, volume of intraoperative packed red blood cells, and aortic cross-clamp time, subclinical and combined AKI remained associated with greater in-hospital mortality than no AKI and clinical AKI (adjusted ORs: 28.118, 95% CI 1.465–539.703; 3.737, 95% CI 1.746–7.998). Cox proportional hazard models found a significant association of biomarker-informed AKI subtypes with long-term survival compared with no AKI (adjusted ORs: pooled subclinical and clinical AKI: 1.885, 95% CI 1.003–3.542; combined AKI: 1.792, 95% CI 1.367–2.350). Conclusions In the presence or absence of KDIGO clinical criteria for AKI, the urinary NGAL/hepcidin-25-ratio appears to detect prognostically relevant AKI subtypes. |
URI: | https://opendata.uni-halle.de//handle/1981185920/103240 http://dx.doi.org/10.25673/101285 |
Open-Access: | Open-Access-Publikation |
Nutzungslizenz: | (CC BY 4.0) Creative Commons Namensnennung 4.0 International |
Sponsor/Geldgeber: | Projekt DEAL 2021 |
Journal Titel: | Journal of nephrology |
Verlag: | Springer |
Verlagsort: | Milano |
Band: | 35 |
Heft: | 2 |
Originalveröffentlichung: | 10.1007/s40620-021-01063-5 |
Seitenanfang: | 597 |
Seitenende: | 605 |
Enthalten in den Sammlungen: | Medizinische Fakultät (OA) |
Dateien zu dieser Ressource:
Datei | Beschreibung | Größe | Format | |
---|---|---|---|---|
Elitok et al._NGAL-hepcidin-25_2022.pdf | Zweitveröffentlichung | 1.81 MB | Adobe PDF | Öffnen/Anzeigen |